10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:T30
Name:CHEMBL244767
Description:
Labels:Train
CAS:
InChi Code:InChI=1S/C30H28N2O6/c1-2-3-4-11-16-24-19-32(30(35)31-28(24)33)18-17-25-26(36-20-22-12-7-5-8-13-22)27(29(34)38-25)37-21-23-14-9-6-10-15-23/h5-10,12-15,17,19H,2-4,18,20-21H2,1H3,(H,31,33,35)/b25-17-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
4.8

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.88602

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Training set)